The Future of AI Design in Medical Devices can you find references and pros and cons on using this topic in a dissertation

Argument (concise) The proposed dissertation topic is timely and important, but left in its current broad form it risks producing work that is diffuse, empirically fragile, and quickly outdated. Four linked problems undercut its suitability unless the scope is narrowed and methodological constraints are addressed. 1. Diffusion of focus - The topic spans algorithmic design, human–device interaction, regulation, ethics, and socioeconomics. Without a tightly defined research question (device class, jurisdiction, or specific design problem), the project is likely to be descriptive rather than providing a coherent theoretical or empirical contribution. See Popper on the value of focused, falsifiable hypotheses (Popper, The Logic of Scientific Discovery, 1959). 2. Rapid obsolescence - AI techniques, commercial deployments, and regulatory frameworks (e.g., FDA AI/ML Action Plan, evolving EU AI Act) change quickly. Broad claims about “the future” risk being outdated over the multi‑year timeline of a dissertation. Targeting enduring conceptual issues (validation epistemology, accountability structures) reduces this risk. 3. Empirical and reproducibility constraints - Cutting‑edge AI medical devices and datasets are often proprietary. Limited access to models/data and non‑disclosure constraints make reproducible experiments and independent verification difficult (Ghassemi et al., Lancet Digital Health, 2021). Strong empirical claims therefore require prearranged partnerships or the use of open datasets. 4. Interdisciplinary and supervisory demands - Addressing technical, clinical, legal, and ethical aspects well requires deep expertise across domains. That breadth can exceed realistic supervisory and time resources, leading to superficial treatment. A defensible dissertation should concentrate on one domain and use interdisciplinary literature for context. Conclusion and suggested remedy The topic is valuable but too broad and vulnerable to empirical and normative pitfalls as stated. The dissertation will be more rigorous and impactful if it narrows to a tractable, high‑impact question — for example: “Validation requirements for continuous‑learning imaging SaMD under FDA and EU frameworks” or “Human‑centered explainability practices that improve clinician adoption of AI radiology tools.” These focused angles preserve relevance while enabling methodological rigor, reproducibility, and a clearer normative stance. Key citations - U.S. Food & Drug Administration. "Artificial Intelligence and Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan." 2021. https://www.fda.gov/media/145022/download - Ghassemi, M., et al. "Practical guidance on artificial intelligence for health‑care data." Lancet Digital Health, 2021. - Hernandez‑Boussard, T., et al. "Hidden in plain sight—reconsidering the regulatory framework for software as a medical device." NEJM, 2020. - Popper, K. R. The Logic of Scientific Discovery. 1959. - Floridi, L., et al. "AI4People—An Ethical Framework for a Good AI Society." Minds and Machines, 2018. If you like, I can turn this critique into a one‑page document for your proposal or propose a narrowed research question with a 3‑chapter outline and suggested data sources.Title: A Short Critique of "The Future of AI Design in Medical Devices — Pros, Cons, and Key References" Argument (concise) Although the proposed dissertation topic is timely and societally important, its breadth and the field’s current conditions risk producing work that is unfocused, empirically fragile, and of limited long‑term scholarly impact. 1. Diffuse scope undermines theoretical clarity - Covering algorithmic design, human–device interaction, regulation, ethics, and socioeconomics in one project makes it hard to develop a single, testable thesis. Without a tightly defined research question (device class, jurisdiction, or problem), the project may default to descriptive synthesis rather than original analysis. (See Popper, The Logic of Scientific Discovery, 1959, on the value of focused, falsifiable hypotheses.) 2. Rapid obsolescence of technical and regulatory claims - AI techniques, product releases, and regulatory frameworks (e.g., FDA AI/ML guidance, evolving EU AI Act) change quickly. Broad prognoses about “the future” risk being outdated before completion, limiting lasting contribution. Focusing on enduring conceptual problems (validation epistemology, accountability mechanisms) is safer. 3. Empirical reproducibility is constrained by proprietary barriers - Many state‑of‑the‑art AI medical devices and datasets are proprietary. Restricted access impedes independent replication and strong empirical claims (Ghassemi et al., Lancet Digital Health, 2021). Unless partnerships or open datasets are secured, empirical sections may be weak. 4. Methodological overstretch and supervisory demands - The topic requires deep expertise across ML, clinical validation, regulatory law, human factors, and ethics. Achieving that breadth during a single doctoral program risks superficial treatment across domains; better to specialize and use other areas for contextualization. 5. Normative and policy ambiguity - Recommending regulatory or ethical prescriptions presumes resolving contested value trade‑offs (safety vs. innovation, equity vs. efficiency). Without an explicit normative framework, policy recommendations may lack persuasive justification and practical uptake (Floridi et al., AI4People, 2018). 6. Measurement difficulties for human factors and outcomes - Demonstrating effects on clinician trust, workflow integration, or patient outcomes typically requires longitudinal, resource‑intensive studies. Short lab studies may not generalize, weakening claims about real‑world impact (Kelly et al., BMC Medicine, 2019). Conclusion and recommended remedy The topic is important but, as framed, is vulnerable to conceptual vagueness, empirical limits, and rapid obsolescence. Strengthen the dissertation by narrowing to a tractable, high‑impact question (for example: “Validation frameworks for continuous‑learning imaging SaMD under FDA and EU rules” or “Explainability practices that improve clinician adoption of AI radiology tools”). A narrowed focus preserves relevance while enabling methodological rigor, reproducibility, and a clearer normative stance. Selected citations - U.S. Food & Drug Administration. "AI/ML‑Based Software as a Medical Device (SaMD) Action Plan." 2021. https://www.fda.gov/media/145022/download - Ghassemi, M., et al. "Practical guidance on artificial intelligence for health‑care data." Lancet Digital Health, 2021. - Kelly, C. J., et al. "Key challenges for delivering clinical impact with artificial intelligence." BMC Medicine, 2019. - Floridi, L., et al. "AI4People—An Ethical Framework for a Good AI Society." Minds and Machines, 2018. - Popper, K. "The Logic of Scientific Discovery." 1959. If you’d like, I can convert this critique into a one‑page proposal response and propose a narrowly scoped alternative research question with a 3‑chapter outline.Title: A Critique of "The Future of AI Design in Medical Devices — Pros, Cons, and Key References" Argument (concise) The proposed dissertation topic is timely and societally important but, as stated, is overly broad and vulnerable to several substantive problems that can undermine its originality, empirical credibility, and lasting contribution. 1. Epistemic diffusion and weak theoretical focus - Covering algorithm design, human–device interaction, regulation, ethics, and socio‑economics risks producing a descriptive catalogue rather than a coherent argument or testable thesis. A doctoral project needs a tightly framed research question to generate falsifiable claims or a clear methodological contribution (cf. Popper, The Logic of Scientific Discovery, 1959). 2. Rapid obsolescence - AI methods and regulatory frameworks (FDA AI/ML Action Plan; EU AI Act drafts) evolve quickly. Broad prognoses about "the future" may be outdated before completion; focusing on enduring conceptual problems (e.g., epistemology of validation, accountability structures) avoids this risk. 3. Empirical and reproducibility constraints - Key data and deployed algorithms are often proprietary. Without industry or clinical partnerships, empirical work may be limited to secondary analyses or simulated studies, weakening claims about real-world safety, generalizability, or performance (Ghassemi et al., Lancet Digital Health, 2021). 4. Methodological overstretch - Competently addressing the full landscape requires deep expertise across ML, clinical validation, human factors, regulatory law, and ethics. Attempting all of this risks superficiality; better to specialize and use other domains as contextual framing. 5. Normative and policy ambiguity - Policy and ethical recommendations depend on contested value trade-offs (safety vs. innovation, equity vs. efficiency). Without an explicit normative framework, prescriptions may be underjustified and of limited practical use (Floridi et al., AI4People, 2018). 6. Measurement and practicality of human‑factors claims - Demonstrating impacts on clinician trust, workflow integration, or patient outcomes usually needs longitudinal, costly studies. Short-term usability studies may not generalize to clinical practice (Kelly et al., BMC Medicine, 2019). Recommended remedy (brief) - Narrow scope: choose one device class (e.g., imaging SaMD), one regulatory jurisdiction (e.g., FDA), or one precise problem (e.g., validation of continuous‑learning algorithms). - Define an explicit normative or theoretical stance if making policy recommendations. - Secure data access via partnerships or use well‑documented open datasets; consider methodological contributions (validation protocols, robustness tests) that are reproducible. - Structure the project to deliver depth in a focused area while situating findings in the broader interdisciplinary debate. Key citations - U.S. Food & Drug Administration. "Artificial Intelligence and Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan." 2021. - Ghassemi, M., et al. "Practical guidance on artificial intelligence for health‑care data." Lancet Digital Health, 2021. - Kelly, C. J., et al. "Key challenges for delivering clinical impact with artificial intelligence." BMC Medicine, 2019. - Floridi, L., et al. "AI4People—An Ethical Framework for a Good AI Society." Minds and Machines, 2018. - Popper, K. R. "The Logic of Scientific Discovery." 1959. If you like, I can turn this critique into: (a) a one‑page proposal critique for submission, or (b) a narrowed research question and 3‑chapter dissertation outline with suggested methods and data sources. Which would be most useful?